Sanyaolu A, et al. Diabetes mellitus: an overview of the types, prevalence, comorbidity, complication, genetics, economic implication, and treatment. World J Meta-Anal. 2023;11(5):134–43.

Article  Google Scholar 

Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131:110708.

Article  PubMed  CAS  Google Scholar 

Albai O et al. Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment. Neuropsychiatr Dis Treat. 2019;15:167–75.

Rizzo MR, et al. Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment. Pharmacol Res. 2022;176:106062.

Article  PubMed  CAS  Google Scholar 

Danquah MO, et al. The utility of the Montreal cognitive assessment (MoCA) in detecting cognitive impairment in surgical populations–a systematic review and meta-analysis. J Clin Anesth. 2024;97:111551.

Article  PubMed  Google Scholar 

You Y, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021;58:671–85.

Article  PubMed  Google Scholar 

Xia Z, et al. Risk prediction models for mild cognitive impairment in patients with type 2 diabetes mellitus: A systematic review and Meta-Analysis. Metabolic Syndrome and Obesity: Diabetes; 2024. pp. 4425–38.

Google Scholar 

Srikanth V, et al. Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8(6):535–45.

Article  PubMed  Google Scholar 

Jessen F, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271–8.

Article  PubMed  PubMed Central  Google Scholar 

Dove A, et al. The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement. 2021;17(11):1769–78.

Article  PubMed  Google Scholar 

Scott SN, et al. Clinical considerations and practical advice for people living with type 2 diabetes who undertake regular exercise or aim to exercise competitively. Diabetes Spectr. 2023;36(2):114–26.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, et al. Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease. Diabetol Metab Syndr. 2023;15(1):229.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pais R, et al. Global cognitive impairment prevalence and incidence in community dwelling older adults—a systematic review. Geriatrics. 2020;5(4):84.

Article  PubMed  PubMed Central  Google Scholar 

Makino K, et al. Diabetes and prediabetes inhibit reversion from mild cognitive impairment to normal cognition. J Am Med Dir Assoc. 2021;22(9):1912–8. e2.

Article  PubMed  Google Scholar 

Gudala K, et al. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4(6):640–50.

Article  PubMed  PubMed Central  Google Scholar 

Badrkhahan SZ, et al. Validity and reliability of the Persian version of the Montreal cognitive assessment (MoCA-P) scale among subjects with Parkinson’s disease. Appl Neuropsychol Adult. 2020. https://doi.org/10.1080/23279095.2019.1565762.

Article  PubMed  Google Scholar 

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bastien CH, Vallières A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.

Article  PubMed  Google Scholar 

Thour A, et al. Anxiety among patients with diabetes mellitus evaluated using generalized anxiety disorder 7-item scale. J Social Health Diabetes. 2016;4(02):133–6.

Article  Google Scholar 

Yang J et al. Relationship between self-care behavior and cognitive function in hospitalized adult patients with type 2 diabetes: a cross-sectional study. Diabetes, Metabolic Syndrome and Obesity, 2020. pp. 207–214.

Koç M, et al. Comparison and validation of scoring systems in a cohort of patients treated for perforated peptic ulcer. Langenbecks Arch Surg. 2007;392:581–5.

Article  PubMed  Google Scholar 

Wabe N, et al. The use and predictive performance of the Peninsula health falls risk assessment tool (PH-FRAT) in 25 residential aged care facilities: a retrospective cohort study using routinely collected data. BMC Geriatr. 2022;22(1):271.

Article  PubMed  PubMed Central  Google Scholar 

Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y-J, et al. Microvascular burden and long-term risk of stroke and dementia in type 2 diabetes mellitus. J Affect Disord. 2024;354:68–74.

Article  PubMed  CAS  Google Scholar 

Tang X, et al. The association between diabetes duration and domain-specific cognitive impairment: a population-based study. J Alzheimers Dis. 2023;91(4):1435–46.

Article  PubMed  CAS  Google Scholar 

Gupta M, et al. Molecular mechanisms underlying hyperglycemia associated cognitive decline. IBRO Neurosci Rep. 2023;14:57–63.

Article  PubMed  Google Scholar 

Li F-R, et al. Influence of diabetes duration and glycemic control on dementia: a cohort study. J Gerontol A Biol Sci Med Sci. 2021;76(11):2062–70.

Article  PubMed  CAS  Google Scholar 

Launer LJ, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10(11):969–77.

Article  PubMed  PubMed Central  Google Scholar 

Koekkoek PS, et al. Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes—the ADDITION-Netherlands study: a cluster-randomized trial. J Neurol Sci. 2012;314(1–2):71–7.

Article  PubMed  Google Scholar 

Umegaki H, et al. Factors associated with cognitive decline in older adults with type 2 diabetes mellitus during a 6-year observation. Volume 15. Geriatrics & gerontology international; 2015. pp. 302–10. 3.

Manschot SM, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55(4):1106–13.

Article  PubMed  CAS  Google Scholar 

Cho S, et al. The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: hospital based retrospective study (2005–2021). Diabetes Res Clin Pract. 2023;201:p110721.

Article  Google Scholar 

Zheng F, et al. HbA1c, diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018;61(4):839–48.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cosway R, et al. Cognitive function and information processing in type 2 diabetes. Diabet Med. 2001;18(10):803–10.

Article  PubMed  CAS  Google Scholar 

Rawlings AM, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42(7):1248–54.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xia W, et al. Glucose fluctuations are linked to disrupted brain functional architecture and cognitive impairment. J Alzheimers Dis. 2020;74(2):603–13.

Article  PubMed  CAS  Google Scholar